Citu, I.M.; Citu, C.; Gorun, F.; Sas, I.; Tomescu, L.; Neamtu, R.; Motoc, A.; Gorun, O.M.; Burlea, B.; Bratosin, F.;
et al. Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester. Viruses 2022, 14, 307.
https://doi.org/10.3390/v14020307
AMA Style
Citu IM, Citu C, Gorun F, Sas I, Tomescu L, Neamtu R, Motoc A, Gorun OM, Burlea B, Bratosin F,
et al. Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester. Viruses. 2022; 14(2):307.
https://doi.org/10.3390/v14020307
Chicago/Turabian Style
Citu, Ioana Mihaela, Cosmin Citu, Florin Gorun, Ioan Sas, Larisa Tomescu, Radu Neamtu, Andrei Motoc, Oana Maria Gorun, Bogdan Burlea, Felix Bratosin,
and et al. 2022. "Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester" Viruses 14, no. 2: 307.
https://doi.org/10.3390/v14020307
APA Style
Citu, I. M., Citu, C., Gorun, F., Sas, I., Tomescu, L., Neamtu, R., Motoc, A., Gorun, O. M., Burlea, B., Bratosin, F., & Malita, D.
(2022). Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester. Viruses, 14(2), 307.
https://doi.org/10.3390/v14020307